ATEC - アルファテック・ホ―ルディングス (Alphatec Holdings Inc.) アルファテック・ホ―ルディングス

 ATECのチャート


 ATECの企業情報

symbol ATEC
会社名 Alphatec Holdings Inc (アルファテック・ホ―ルディングス)
分野(sector) Health Care   ヘルスケア
産業(industry) Medical/Dental Instruments  
業種 先端医療機器_テクノロジ―   医療関連(Health Care)
概要 事業概要 アルファテック・ホールディングス(Alphatec Holdings Inc.)は主に脊椎疾患の外科治療用製品の設計・開発・製造・販売に従事する医療技術会社。同社の製品ポートフォリオとパイプラインは脊椎の頸椎、胸腰椎と椎間部分に対処できて、一連の脊髄障害と医療手当をカバーする。同社の主要製品は世界市場を中心とし、整形外科の脊椎疾患ソリューションのために提供される。同社の主要製品は多様な脊椎移植製品やシステムにより構成され、脊椎スクリューとロッド、脊椎スペーサー、プレート、および様々な生物学的製剤を含む。また、同社は米国以外において、脊椎圧迫骨折と脊柱管狭窄症の治療ソリューションを販売する。   アルファテック・ホ―ルディングスは、米国の医療機器持株会社。脊椎疾患の外科的治療用製品の設計、開発、製造、販売を行う。頸椎、頸胸椎、胸腰椎などの脊髄障害向けにAvalon、Solanas、Zodiac、Arsenal、Aspidaや、椎間スペ―サ―のNOVEL ALS、低侵襲手術用BridgePoint、および生物製剤を提供する。   Alphatec Holdings, Inc. (ATEC), through its wholly-owned subsidiaries, Alphatec Spine, Inc. and SafeOp Surgical, Inc., is a medical device company dedicated to revolutionizing the approach to spine surgery through clinical distinction. ATEC's Organic Innovation Machine is focused on developing new approaches that integrate seamlessly with the SafeOp Neural InformatiX System to safely and reproducibly treat spine's various pathologies and achieve the goals of spine surgery. Alphatec's ultimate vision is to be the Standard Bearer in Spine.
本社所在地 5818 El Camino Real Carlsbad CA 92008 USA
代表者氏名 Patrick S. Miles パトリック・S・マイルズ
代表者役職名 Chairman of the Board Chief Executive Officer 取締役会長兼最高経営責任者
電話番号 +1 760-431-9286
設立年月日 38412
市場名 NASDAQ National Market System
ipoyear 2006年
従業員数 430人
url www.alphatecspine.com
nasdaq_url https://www.nasdaq.com/symbol/atec
adr_tso
EBITDA EBITDA(百万ドル) -8.39600
終値(lastsale) 3
時価総額(marketcap) 127188198
時価総額 時価総額(百万ドル) 127.18820
売上高 売上高(百万ドル) 92.73100
企業価値(EV) 企業価値(EV)(百万ドル) 146.22720
当期純利益 当期純利益(百万ドル) -5.40500
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Alphatec Holdings Inc revenues decreased 17% to $43.3M. Net loss before extraordinary items increased 11% to $8.9M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Gain on sale of assets decrease from $856K (income) to $0K Amortization of intangible assets increase of 6% to $364K (expense) Other income (expense).

 ATECのテクニカル分析


 ATECのニュース

   $78.06 Million in Sales Expected for Alphatec Holdings, Inc. This Quarter  2022/06/06 07:59:09 Business Mag
Analysts expect Alphatec Holdings, Inc. to post $78.06 million in sales for the current fiscal quarter, according to Zacks Investment Research. Three analysts have provided…
   During The Past Six Months, Alphatec Holdings Inc. (NASDAQ: ATEC) Shares Took An -33.03% Jump. Here Is What We Should Expect  2022/06/04 12:00:00 Marketing Sentinel
During the last session, Alphatec Holdings Inc. (NASDAQ:ATEC)’s traded shares were 0.42 million, with the beta value of the company hitting 1.63. At the end of the trading day, the stock’s price was $7.40, reflecting an intraday loss of -1.99% or -$0.15. The 52-week high for the ATEC share is $16.47, that puts it down … During The Past Six Months, Alphatec Holdings Inc. (NASDAQ: ATEC) Shares Took An -33.03% Jump. Here Is What We Should Expect Read More »
   Spine Implants Global Market Report 2022  2022/05/26 12:48:00 GlobeNewswire
Major players in the spine implants market are Medtronic, Depuy Synthes, Johnson & Johnson, Stryker Corporation, NuVasive, Inc. , Zimmer Biomet Holdings, Globus Medical, Alphatec Holdings, Orthofix International, and RTI Surgical. Major players in the spine implants market are Medtronic, Depuy Synthes, Johnson & Johnson, Stryker Corporation, NuVasive, Inc. , Zimmer Biomet Holdings, Globus Medical, Alphatec Holdings, Orthofix International, and RTI Surgical.
   ATEC to Participate in Upcoming Investor Events  2022/05/19 13:00:00 Wallstreet:Online
Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, announced today that executive management will participate in the following investor events: Todd Koning, Chief Financial Officer, will present at the Wells Fargo Securities West Coast MedTech Tour on June 2, 2022, at 11:30am PDT. Pat Miles,
   Technology - Alphatec Downgraded by Zacks Investment Research to “Sell”  2022/05/10 21:57:34 Business Mag
Alphatec was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Tuesday, Zacks.com reports…
   $66.59 Million in Sales Expected for Alphatec Holdings, Inc. (NASDAQ:ATEC) This Quarter  2021/12/23 08:56:43 Dakota Financial News
Analysts expect Alphatec Holdings, Inc. (NASDAQ:ATEC) to report $66.59 million in sales for the current quarter, Zacks Investment Research reports. Four analysts have made estimates for Alphatecs earnings. The lowest sales estimate is $65.67 million and the highest is $68.00 million. Alphatec posted sales of $43.95 million during the same quarter last year, which would []
   Insider Buying: Alphatec Holdings, Inc. (NASDAQ:ATEC) Director Purchases $54,200.00 in Stock  2021/12/19 12:18:47 Transcript Daily
Alphatec Holdings, Inc. (NASDAQ:ATEC) Director Jason Hochberg acquired 5,000 shares of the companys stock in a transaction dated Wednesday, December 15th. The shares were bought at an average cost of $10.84 per share, for a total transaction of $54,200.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can []
   James L. L. Tullis Sells 20,000 Shares of Alphatec Holdings, Inc. (NASDAQ:ATEC) Stock  2021/12/15 11:20:43 Dakota Financial News
Alphatec Holdings, Inc. (NASDAQ:ATEC) Director James L. L. Tullis sold 20,000 shares of the companys stock in a transaction that occurred on Thursday, December 9th. The shares were sold at an average price of $11.78, for a total transaction of $235,600.00. The sale was disclosed in a legal filing with the SEC, which is accessible []
   Perkins Capital Management Inc. Sells 5,150 Shares of Alphatec Holdings, Inc. (NASDAQ:ATEC)  2021/12/09 16:04:43 Transcript Daily
Perkins Capital Management Inc. trimmed its position in shares of Alphatec Holdings, Inc. (NASDAQ:ATEC) by 2.9% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 171,600 shares of the medical technology companys stock after selling 5,150 shares during the quarter. Alphatec makes up about 1.3% of Perkins Capital Management Inc.s portfolio, making the stock its []
   Brokerages Set Alphatec Holdings, Inc. (NASDAQ:ATEC) Price Target at $20.64  2021/12/08 01:58:41 Dakota Financial News
Shares of Alphatec Holdings, Inc. (NASDAQ:ATEC) have received an average recommendation of Buy from the nine research firms that are currently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, one has given a hold rating and six have given a buy rating to the company. The []
   Perkins Capital Management Inc. Sells 5,150 Shares of Alphatec Holdings, Inc. (NASDAQ:ATEC)  2021/12/09 16:04:43 Transcript Daily
Perkins Capital Management Inc. trimmed its position in shares of Alphatec Holdings, Inc. (NASDAQ:ATEC) by 2.9% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 171,600 shares of the medical technology companys stock after selling 5,150 shares during the quarter. Alphatec makes up about 1.3% of Perkins Capital Management Inc.s portfolio, making the stock its []
   Brokerages Set Alphatec Holdings, Inc. (NASDAQ:ATEC) Price Target at $20.64  2021/12/08 01:58:41 Dakota Financial News
Shares of Alphatec Holdings, Inc. (NASDAQ:ATEC) have received an average recommendation of Buy from the nine research firms that are currently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, one has given a hold rating and six have given a buy rating to the company. The []
   Alphatec (NASDAQ:ATEC) Research Coverage Started at The Goldman Sachs Group  2021/12/06 07:18:43 Transcript Daily
The Goldman Sachs Group started coverage on shares of Alphatec (NASDAQ:ATEC) in a report issued on Friday, Price Targets.com reports. The firm issued a neutral rating and a $12.50 price target on the medical technology companys stock. Several other research firms also recently commented on ATEC. Loop Capital assumed coverage on shares of Alphatec in []
   Alphatec (NASDAQ:ATEC) Receives New Coverage from Analysts at The Goldman Sachs Group  2021/12/03 12:10:42 Dakota Financial News
Research analysts at The Goldman Sachs Group initiated coverage on shares of Alphatec (NASDAQ:ATEC) in a report issued on Friday, The Fly reports. The brokerage set a neutral rating and a $12.50 price target on the medical technology companys stock. The Goldman Sachs Groups target price would indicate a potential upside of 13.12% from the []
   Zacks: Brokerages Anticipate Alphatec Holdings, Inc. (NASDAQ:ATEC) Will Announce Earnings of -$0.30 Per Share  2021/12/01 10:38:41 Transcript Daily
Brokerages expect Alphatec Holdings, Inc. (NASDAQ:ATEC) to announce earnings per share (EPS) of ($0.30) for the current fiscal quarter, according to Zacks Investment Research. Four analysts have made estimates for Alphatecs earnings. The lowest EPS estimate is ($0.37) and the highest is ($0.27). Alphatec posted earnings of ($0.22) per share in the same quarter last []

 関連キーワード  (先端医療機器_テクノロジ― 米国株 アルファテック・ホ―ルディングス ATEC Alphatec Holdings Inc.)

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)